2011
DOI: 10.1136/bcr.03.2011.3938
|View full text |Cite
|
Sign up to set email alerts
|

Retroperitoneal unicentric Castleman's disease with multiple lymph node involvement

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2014
2014
2017
2017

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 8 publications
0
2
0
Order By: Relevance
“…Recently, some authors has demonstrated surgical cure by oncological resection. Schulte et al 16 reported that if possible oncological resection must be performed for disseminated CD. When complete resection is impossible, palliative resection or radiotherapy may be used to control possible systemic manifestations 4,9 .…”
Section: Discussionmentioning
confidence: 99%
“…Recently, some authors has demonstrated surgical cure by oncological resection. Schulte et al 16 reported that if possible oncological resection must be performed for disseminated CD. When complete resection is impossible, palliative resection or radiotherapy may be used to control possible systemic manifestations 4,9 .…”
Section: Discussionmentioning
confidence: 99%
“…Castleman's disease is categorized as hyaline vascular type and plasma cell type by histology [ 6 ]. By involved solitary or multiple lymph node sites, Castleman's disease is classifi ed as unicentric and multicentric diseases [ 7 ]. Hyaline vascular type of retroperitoneal Castleman's disease typically shows homogeneous density and homogeneous moderate to strong enhancement on computed tomography (CT), as well as hypointense on T1-weighted image and hyperintense on T2-weighted image on magnetic resonance imaging (MRI) [ 6 , 7 ].…”
Section: Key Diagnostic Featuresmentioning
confidence: 99%